Allspring Global Investments Holdings LLC Sells 16,143 Shares of The Clorox Company (NYSE:CLX)

Allspring Global Investments Holdings LLC lessened its stake in shares of The Clorox Company (NYSE:CLX) by 10.0% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 145,429 shares of the company’s stock after selling 16,143 shares during the quarter. Allspring Global Investments Holdings LLC owned about 0.12% of Clorox worth $23,692,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in CLX. Van ECK Associates Corp boosted its stake in Clorox by 1,715.5% during the 2nd quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock valued at $199,411,000 after purchasing an additional 1,380,724 shares during the period. Nuance Investments LLC boosted its stake in Clorox by 150.6% during the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after purchasing an additional 960,094 shares during the period. Wulff Hansen & CO. boosted its stake in Clorox by 13,547.0% during the 2nd quarter. Wulff Hansen & CO. now owns 440,116 shares of the company’s stock valued at $60,063,000 after purchasing an additional 436,891 shares during the period. Acadian Asset Management LLC boosted its stake in Clorox by 26.5% during the 1st quarter. Acadian Asset Management LLC now owns 882,526 shares of the company’s stock valued at $135,099,000 after purchasing an additional 184,847 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in Clorox by 14.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock valued at $131,200,000 after purchasing an additional 120,716 shares during the period. Institutional investors own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. BNP Paribas upgraded Clorox to a “strong sell” rating in a research report on Friday, September 6th. TD Cowen assumed coverage on Clorox in a research report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price objective for the company. JPMorgan Chase & Co. raised their price objective on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and raised their price objective for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. Finally, DA Davidson reiterated a “neutral” rating and issued a $153.00 price objective on shares of Clorox in a research report on Friday, September 6th. Six investment analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, Clorox has an average rating of “Hold” and a consensus price target of $150.14.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.51% of the company’s stock.

Clorox Trading Down 0.1 %

CLX stock opened at $159.04 on Thursday. The business has a fifty day moving average price of $160.25 and a 200 day moving average price of $145.43. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The stock has a market capitalization of $19.75 billion, a price-to-earnings ratio of 82.40, a P/E/G ratio of 3.19 and a beta of 0.41. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The firm had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Analysts expect that The Clorox Company will post 6.64 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.07%. Clorox’s dividend payout ratio is 252.85%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.